
|
Three
Months Ended
|
Twelve
Months Ended
|
|||||||||||||||
|
Jan-02,
|
Dec-28,
|
Jan-02,
|
Dec-28,
|
|||||||||||||
|
2009
|
2007
|
2009
|
2007
|
|||||||||||||
|
Revenue
|
$ | 268,084 | $ | 312,783 | $ | 1,329,234 | $ | 1,222,270 | ||||||||
|
Cost
of sales
|
146,046 | 157,117 | 680,098 | 609,365 | ||||||||||||
|
Gross
margin
|
122,038 | 155,666 | 649,136 | 612,905 | ||||||||||||
|
Gross
margin (%)
|
45.5 | % | 49.8 | % | 48.8 | % | 50.1 | % | ||||||||
|
Operating
expenses
|
||||||||||||||||
|
Research
and development
|
36,168 | 34,731 | 148,265 | 131,468 | ||||||||||||
|
Sales
and marketing
|
44,563 | 51,528 | 196,290 | 186,495 | ||||||||||||
|
General
and administrative
|
23,972 | 25,390 | 94,023 | 92,572 | ||||||||||||
|
Restructuring
|
287 | - | 2,722 | 3,025 | ||||||||||||
|
Amortization
of purchased intangible assets
|
6,608 | 4,754 | 22,376 | 18,966 | ||||||||||||
|
In-process
research and development
|
- | - | - | 2,112 | ||||||||||||
|
Total
operating expenses
|
111,598 | 116,403 | 463,676 | 434,638 | ||||||||||||
|
Operating
income
|
10,440 | 39,263 | 185,460 | 178,267 | ||||||||||||
|
Non-operating
income (expense), net
|
||||||||||||||||
|
Interest
income
|
675 | 896 | 2,044 | 3,502 | ||||||||||||
|
Interest
expense
|
(1,371 | ) | (1,127 | ) | (2,760 | ) | (6,602 | ) | ||||||||
|
Foreign
currency transaction gain (loss), net
|
(829 | ) | (819 | ) | 1,509 | (1,351 | ) | |||||||||
|
Income
from joint ventures, net
|
1,185 | 1,932 | 7,981 | 8,377 | ||||||||||||
|
Minority
interests in consolidated subsidiaries
|
519 | 6 | 540 | 6 | ||||||||||||
|
Other
income (expense), net
|
(1,130 | ) | 384 | (2,812 | ) | 1,557 | ||||||||||
|
Total
non-operating income (expense), net
|
(951 | ) | 1,272 | 6,502 | 5,489 | |||||||||||
|
Income before
taxes
|
9,489 | 40,535 | 191,962 | 183,756 | ||||||||||||
|
Income
tax provision (benefit)
|
(4,250 | ) | 14,244 | 50,490 | 66,382 | |||||||||||
|
Net
income
|
$ | 13,739 | $ | 26,291 | $ | 141,472 | $ | 117,374 | ||||||||
|
Earnings
per share :
|
||||||||||||||||
|
Basic
|
$ | 0.12 | $ | 0.22 | $ | 1.17 | $ | 0.98 | ||||||||
|
Diluted
|
$ | 0.11 | $ | 0.21 | $ | 1.14 | $ | 0.94 | ||||||||
|
Shares
used in calculating earnings per share :
|
||||||||||||||||
|
Basic
|
119,342 | 121,428 | 120,714 | 119,280 | ||||||||||||
|
Diluted
|
121,728 | 126,532 | 124,235 | 124,410 | ||||||||||||

|
Jan-02,
|
Dec-28,
|
|||||||
|
2009
|
2007
|
|||||||
|
Assets
|
||||||||
|
Current
assets:
|
||||||||
|
Cash
and cash equivalents
|
$ | 147,531 | $ | 103,202 | ||||
|
Accounts
receivables, net
|
204,269 | 239,884 | ||||||
|
Other
receivables
|
17,540 | 10,201 | ||||||
|
Inventories,
net
|
160,893 | 143,018 | ||||||
|
Deferred
income taxes
|
41,810 | 44,333 | ||||||
|
Other
current assets
|
16,404 | 15,661 | ||||||
|
Total
current assets
|
588,447 | 556,299 | ||||||
|
Property
and equipment, net
|
50,175 | 51,444 | ||||||
|
Goodwill
|
715,571 | 675,850 | ||||||
|
Other
purchased intangible assets, net
|
228,901 | 197,777 | ||||||
|
Other
non-current assets
|
51,922 | 57,989 | ||||||
|
Total
assets
|
$ | 1,635,016 | $ | 1,539,359 | ||||
|
Liabilities
and Shareholders' Equity
|
||||||||
|
Current
liabilities:
|
||||||||
|
Current
portion of long-term debt
|
$ | 124 | $ | 126 | ||||
|
Accounts
payable
|
49,611 | 67,589 | ||||||
|
Accrued
compensation and benefits
|
41,291 | 55,133 | ||||||
|
Deferred
revenue
|
55,241 | 49,416 | ||||||
|
Accrued
warranty expense
|
13,332 | 10,806 | ||||||
|
Income
taxes payable
|
- | 14,802 | ||||||
|
Other
accrued liabilities
|
63,719 | 51,980 | ||||||
|
Total
current liabilities
|
223,318 | 249,852 | ||||||
|
Non-current
portion of long-term debt
|
151,464 | 60,564 | ||||||
|
Non-current
deferred revenue
|
12,418 | 15,872 | ||||||
|
Deferred
income taxes
|
42,207 | 47,917 | ||||||
|
Other
non-current liabilities
|
61,553 | 56,128 | ||||||
|
Total
liabilities
|
490,960 | 430,333 | ||||||
|
Minority
interests in consolidated subsidiaries
|
3,655 | - | ||||||
|
Commitments
and contingencies
|
||||||||
|
Shareholders'
equity:
|
||||||||
|
Common
stock
|
684,831 | 660,749 | ||||||
|
Retained
earnings
|
427,921 | 388,557 | ||||||
|
Accumulated
other comprehensive income
|
27,649 | 59,720 | ||||||
|
Total
shareholders' equity
|
1,140,401 | 1,109,026 | ||||||
|
Total
liabilities and shareholders' equity
|
$ | 1,635,016 | $ | 1,539,359 | ||||

|
Twelve
Months Ended
|
||||||||
|
Jan-02,
|
Dec-28,
|
|||||||
|
2009
|
2007
|
|||||||
|
Cash
flow from operating activities:
|
||||||||
|
Net
Income
|
$ | 141,472 | $ | 117,374 | ||||
|
Adjustments
to reconcile net income to net cash provided by operating
activities:
|
||||||||
|
Depreciation
expense
|
19,047 | 17,212 | ||||||
|
Amortization
expense
|
45,066 | 38,744 | ||||||
|
Provision
for doubtful accounts
|
2,709 | 1,410 | ||||||
|
Amortization
of debt issuance cost
|
169 | 218 | ||||||
|
Deferred
income taxes
|
(17,356 | ) | 6,368 | |||||
|
Non-cash
restructuring expense
|
- | 1,725 | ||||||
|
Stock-based
compensation
|
16,166 | 15,016 | ||||||
|
In-process
research and development
|
- | 2,112 | ||||||
|
Equity
gain from joint ventures
|
(7,981 | ) | (8,377 | ) | ||||
|
Excess
tax benefit for stock-based compensation
|
(5,970 | ) | (12,409 | ) | ||||
|
Provision
for excess and obsolete inventories
|
4,426 | 4,352 | ||||||
|
Other
non-cash items
|
(348 | ) | 651 | |||||
|
Add
decrease (increase) in assets:
|
||||||||
|
Accounts
receivables
|
33,414 | (35,696 | ) | |||||
|
Other
receivables
|
(7,422 | ) | 4,825 | |||||
|
Inventories
|
(16,461 | ) | (18,678 | ) | ||||
|
Other
current and non-current assets
|
779 | 7,650 | ||||||
|
Add
increase (decrease) in liabilities:
|
||||||||
|
Accounts
payable
|
(20,898 | ) | (3,521 | ) | ||||
|
Accrued
compensation and benefits
|
(12,487 | ) | 1,691 | |||||
|
Accrued
liabilities
|
3,183 | (4,635 | ) | |||||
|
Deferred
revenue
|
(1,320 | ) | 32,400 | |||||
|
Income
taxes payable
|
(114 | ) | 18,553 | |||||
|
Net
cash provided by operating activities
|
176,074 | 186,985 | ||||||
|
Cash
flows from investing activities:
|
||||||||
|
Acquisitions
of businesses, net of cash acquired
|
(115,137 | ) | (295,848 | ) | ||||
|
Acquisition
of property and equipment
|
(16,196 | ) | (13,187 | ) | ||||
|
Purchases
of debt and equity securities
|
- | (5,576 | ) | |||||
|
Dividends
received
|
10,648 | 2,888 | ||||||
|
Capital
infusion from minority investor
|
4,200 | - | ||||||
|
Other
|
(5,211 | ) | 331 | |||||
|
Net
cash used in investing activities
|
(121,696 | ) | (311,392 | ) | ||||
|
Cash
flow from financing activities:
|
||||||||
|
Issuance
of common stock
|
22,802 | 31,864 | ||||||
|
Excess
tax benefit for stock-based compensation
|
5,970 | 12,409 | ||||||
|
Repurchase
and retirement of common stock
|
(125,888 | ) | - | |||||
|
Proceeds
from long-term debt and revolving credit lines
|
151,000 | 250,000 | ||||||
|
Payments
on long-term debt and revolving credit lines
|
(60,314 | ) | (190,457 | ) | ||||
|
Other
|
(11 | ) | - | |||||
|
Net
cash provided by (used in) financing activities
|
(6,441 | ) | 103,816 | |||||
|
Effect
of exchange rate changes on cash and cash equivalents
|
(3,608 | ) | (5,828 | ) | ||||
|
Net
increase(decrease) in cash and cash equivalents
|
44,329 | (26,419 | ) | |||||
|
Cash
and cash equivalents - beginning of period
|
103,202 | 129,621 | ||||||
|
Cash
and cash equivalents - end of period
|
$ | 147,531 | $ | 103,202 | ||||

|
Three Months Ended
|
Twelve Months Ended
|
||||||||||||||||
|
Jan-02,
|
Dec-28,
|
Jan-02,
|
Dec-28,
|
||||||||||||||
|
2009
|
2007
|
2009
|
2007
|
||||||||||||||
|
REVENUE:
|
$ | 268,084 | $ | 312,783 | $ | 1,329,234 | $ | 1,222,270 | |||||||||
|
GROSS
MARGIN:
|
|||||||||||||||||
|
GAAP
gross margin:
|
$ | 122,038 | $ | 155,666 | $ | 649,136 | $ | 612,905 | |||||||||
|
Restructuring
|
( A
)
|
559 | - | 1,919 | - | ||||||||||||
|
Amortization
of purchased intangibles
|
( B
)
|
5,418 | 5,330 | 22,515 | 19,619 | ||||||||||||
|
Stock-based
compensation
|
( D
)
|
487 | 493 | 1,920 | 1,733 | ||||||||||||
|
Amortization
of acquisition-related inventory step-up
|
( E
)
|
813 | - | 1,414 | - | ||||||||||||
|
Non-GAAP
gross margin:
|
$ | 129,315 | $ | 161,489 | $ | 676,904 | $ | 634,257 | |||||||||
|
Non-GAAP
gross margin (% of revenue)
|
48.2 | % | 51.6 | % | 50.9 | % | 51.9 | % | |||||||||
|
OPERATING
EXPENSES:
|
|||||||||||||||||
|
GAAP
operating expenses:
|
$ | 111,598 | $ | 116,403 | $ | 463,676 | $ | 434,638 | |||||||||
|
Restructuring
|
( A
)
|
(287 | ) | - | (2,722 | ) | (3,025 | ) | |||||||||
|
Amortization
of purchased intangibles
|
( B
)
|
(6,608 | ) | (4,754 | ) | (22,376 | ) | (18,966 | ) | ||||||||
|
In-process
research and development
|
( C
)
|
- | - | - | (2,112 | ) | |||||||||||
|
Stock-based
compensation
|
( D
)
|
(4,076 | ) | (3,574 | ) | (14,246 | ) | (13,283 | ) | ||||||||
|
Non-GAAP
operating expenses:
|
$ | 100,627 | $ | 108,075 | $ | 424,332 | $ | 397,252 | |||||||||
|
OPERATING
INCOME:
|
|||||||||||||||||
|
GAAP
operating income:
|
$ | 10,440 | $ | 39,263 | $ | 185,460 | $ | 178,267 | |||||||||
|
Restructuring
|
( A
)
|
846 | - | 4,641 | 3,025 | ||||||||||||
|
Amortization
of purchased intangibles
|
( B
)
|
12,026 | 10,084 | 44,891 | 38,585 | ||||||||||||
|
In-process
research and development
|
( C
)
|
- | - | - | 2,112 | ||||||||||||
|
Stock-based
compensation
|
( D
)
|
4,563 | 4,067 | 16,166 | 15,016 | ||||||||||||
|
Amortization
of acquisition-related inventory step-up
|
( E
)
|
813 | - | 1,414 | - | ||||||||||||
|
Non-GAAP
operating income:
|
$ | 28,688 | $ | 53,414 | $ | 252,572 | $ | 237,005 | |||||||||
|
Non-GAAP
operating margin (% of revenue)
|
10.7 | % | 17.1 | % | 19.0 | % | 19.4 | % | |||||||||
|
NET
INCOME:
|
|||||||||||||||||
|
GAAP
net income:
|
$ | 13,739 | $ | 26,291 | $ | 141,472 | $ | 117,374 | |||||||||
|
Restructuring
|
( A
)
|
846 | - | 4,641 | 3,025 | ||||||||||||
|
Amortization
of purchased intangibles
|
( B
)
|
12,026 | 10,084 | 44,891 | 38,585 | ||||||||||||
|
In-process
research and development
|
( C
)
|
- | - | - | 2,112 | ||||||||||||
|
Stock-based
compensation
|
( D
)
|
4,563 | 4,067 | 16,166 | 15,016 | ||||||||||||
|
Amortization
of acquisition-related inventory step-up
|
( E
)
|
813 | - | 1,414 | - | ||||||||||||
|
Income
tax effect on non-GAAP adjustments
|
( F
)
|
(3,029 | ) | (4,973 | ) | (17,649 | ) | (21,035 | ) | ||||||||
|
Non-GAAP
net income:
|
$ | 28,958 | $ | 35,469 | $ | 190,935 | $ | 155,077 | |||||||||
|
DILUTED
NET INCOME PER SHARE:
|
|||||||||||||||||
|
GAAP
diluted net income per share:
|
$ | 0.11 | $ | 0.21 | $ | 1.14 | $ | 0.94 | |||||||||
|
Non-GAAP
diluted net income per share:
|
$ | 0.24 | $ | 0.28 | $ | 1.54 | $ | 1.25 | |||||||||
|
SHARES
USED TO COMPUTE DILUTED NET INCOME PER SHARE:
|
|||||||||||||||||
|
GAAP
and Non-GAAP shares used to compute net income per share:
|
121,728 | 126,532 | 124,235 | 124,410 | |||||||||||||
|
OPERATING
LEVERAGE:
|
|||||||||||||||||
|
Increase
(decrease) in non-GAAP operating income
|
$ | (24,726 | ) | $ | 15,567 | ||||||||||||
|
Increase
(decrease) in revenue
|
$ | (44,699 | ) | $ | 106,964 | ||||||||||||
|
Operating
leverage (increase in non-GAAP operating income as a % of increase in
revenue)
|
N/A | 14.6 | % | ||||||||||||||
|
|
(A) Restructuring.
The amounts recorded are for employee compensation resulting from
reductions in employee headcount in connection with our company
restructurings and we believe they are not directly related to the
operation of our business.
|
|
|
(B) Amortization
of purchased intangibles. The amounts recorded as amortization
of purchased intangibles arise from prior acquisitions and are non-cash in
nature. We exclude these expenses because we believe they are
not reflective of ongoing operating results in the period incurred and are
not directly related to the operation of our
business.
|
|
|
(C) In-process
research and development. The amounts recorded as in-process research and
development arise from prior acquisitions and are non-cash in
nature. We exclude these expenses because we believe they are
not reflective of ongoing operating results in the period incurred and not
directly related to the operation of our
business.
|
|
|
(D) Stock-based
Compensation. We exclude these stock-based compensation expenses because
they are non-cash expenses that we believe are not reflective of ongoing
operation results. For the three and nine months ended
September 26, 2008 and September 28, 2007, stock-based compensation was
allocated as follows:
|
|
Three
Months
|
Twelve
Months
|
|||||||||||||||
|
|
Ended
|
Ended
|
||||||||||||||
|
|
Jan-02,
|
Dec-28,
|
Jan-02,
|
Dec-28,
|
||||||||||||
|
|
2009
|
2007
|
2009
|
2007
|
||||||||||||
|
Cost
of sales
|
$ | 487 | $ | 493 | $ | 1,920 | $ | 1,733 | ||||||||
|
Research
and development
|
860 | 954 | 3,489 | 3,573 | ||||||||||||
|
Sales
and Marketing
|
1,095 | 1,091 | 3,993 | 3,891 | ||||||||||||
|
General
and administrative
|
2,121 | 1,529 | 6,764 | 5,819 | ||||||||||||
|
|
$ | 4,563 | $ | 4,067 | $ | 16,166 | $ | 15,016 | ||||||||
|
|
(E) Amortization
of acquisition-related inventory step-up. The purchase accounting entries
associated with our business acquisitions require us to record inventory
at its fair value, which is sometimes greater than the previous book value
of the inventory. The increase in inventory value is amortized
to cost of sales over the period that the related product is
sold. We exclude inventory step-up amortization from our
non-GAAP measures because we do not believe it is reflective of our
ongoing operating results, and it is not used by management to assess the
core profitability of our business operations.
|
|
|
(F) Income
tax effect on non-GAAP adjustments. This amounts adjusts the provision for
income taxes to reflect the effect of the non-GAAP adjustments on non-GAAP
operating
income.
|

|
Reporting Segments
|
|||||||||||||||||
|
Engineering
|
|||||||||||||||||
|
and
|
Field
|
Mobile
|
Advanced
|
||||||||||||||
|
Construction
|
Solutions
|
Solutions
|
Devices
|
||||||||||||||
|
THREE
MONTHS ENDED JANUARY 2, 2009:
|
|||||||||||||||||
|
Revenue
|
$ | 142,613 | $ | 58,245 | $ | 39,995 | $ | 27,231 | |||||||||
|
GAAP
operating income before corporate allocations:
|
$ | 2,339 | $ | 17,528 | $ | 3,331 | $ | 6,340 | |||||||||
|
Stock-based
compensation
|
( G
)
|
1,533 | 221 | 1,167 | 399 | ||||||||||||
|
Non-GAAP
operating income before corporate allocations:
|
$ | 3,872 | $ | 17,749 | $ | 4,498 | $ | 6,739 | |||||||||
|
Non-GAAP
operating margin (% of segment external net revenues)
|
2.7 | % | 30.5 | % | 11.2 | % | 24.7 | % | |||||||||
|
THREE
MONTHS ENDED DECEMBER 28, 2007:
|
|||||||||||||||||
|
Revenue
|
$ | 186,699 | $ | 49,616 | $ | 47,685 | $ | 28,783 | |||||||||
|
GAAP
operating income before corporate allocations:
|
$ | 36,818 | $ | 13,976 | $ | 5,739 | $ | 3,656 | |||||||||
|
Stock-based
compensation
|
( G
)
|
1,073 | 232 | 1,306 | 368 | ||||||||||||
|
Non-GAAP
operating income before corporate allocations:
|
$ | 37,891 | $ | 14,208 | $ | 7,045 | $ | 4,024 | |||||||||
|
Non-GAAP
operating margin (% of segment external net revenues)
|
20.3 | % | 28.6 | % | 14.8 | % | 14.0 | % | |||||||||
|
TWELVE
MONTHS ENDED JANUARY 2, 2009:
|
|||||||||||||||||
|
Revenue
|
$ | 741,670 | $ | 300,706 | $ | 167,113 | $ | 119,745 | |||||||||
|
GAAP
operating income before corporate allocations:
|
$ | 126,014 | $ | 109,489 | $ | 11,328 | $ | 24,445 | |||||||||
|
Stock-based
compensation
|
( G
)
|
4,726 | 821 | 4,749 | 1,378 | ||||||||||||
|
Non-GAAP
operating income before corporate allocations:
|
$ | 130,740 | $ | 110,310 | $ | 16,077 | $ | 25,823 | |||||||||
|
Non-GAAP
operating margin (% of segment external net revenues)
|
17.6 | % | 36.7 | % | 9.6 | % | 21.6 | % | |||||||||
|
TWELVE
MONTHS ENDED DECEMBER 28, 2007:
|
|||||||||||||||||
|
Revenue
|
$ | 743,291 | $ | 200,614 | $ | 157,673 | $ | 120,692 | |||||||||
|
GAAP
operating income before corporate allocations:
|
$ | 174,177 | $ | 60,933 | $ | 12,517 | $ | 17,276 | |||||||||
|
Stock-based
compensation
|
( G
)
|
3,614 | 763 | 4,976 | 1,369 | ||||||||||||
|
Non-GAAP
operating income before corporate allocations:
|
$ | 177,791 | $ | 61,696 | $ | 17,493 | $ | 18,645 | |||||||||
|
Non-GAAP
operating margin (% of segment external net revenues)
|
23.9 | % | 30.8 | % | 11.1 | % | 15.4 | % | |||||||||
|
( G
)
|
Stock-based
Compensation. The amounts consist of expenses for employee stock
options and purchase rights under our employee stock purchase plan
determined in accordance with SFAS 123(R), which became effective for us
on January 1, 2006. We discuss our operating results by segment
with and with-out stock-based compensation expense, as we believe it is
useful to investors to understand the impact of the application of SFAS
123(R) to our results of operations. Stock-based compensation
not allocated to the reportable segments was approximately $1,243K and
$1,088K for the three months ended January 2, 2009 and December 28, 2007,
respectively and $4,492K and $4,294K for the twelve months ended January
2, 2009 and December 28, 2007, respectively.
|